好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Wild-Type Microglia Are Less Neurotoxic Than Mutant SOD1[sup]G93A[/sup] Microglia
Anterior Horn
(-)
004
Authors/Disclosures
Qin Xiao, MD, PhD No disclosure on file
Kevin S. Attenhofer, MD No disclosure on file
Weihua Zhao, MD (Houston Methodist Neurological Institute, Houston Methodist Hospital) No disclosure on file
No disclosure on file
Dominique Monlezun, Jr No disclosure on file
David R. Beers, PhD (Houston Methodist Neurological Institute) No disclosure on file
Laurie A. Schluter, RN, MSN, FNP (NP Health Solutions) No disclosure on file
Albert A. Yen, MD No disclosure on file
Alyana Samai No disclosure on file
No disclosure on file
Digvijaya D. Navalkele, MD (Emory University) Dr. Navalkele has nothing to disclose.
Jenny Henkel, PhD No disclosure on file
Sheryl Martin-Schild, MD, PhD, FAAN (Dr. Brain, Inc.) No disclosure on file
Stanley H. Appel, MD, FAAN (Methodist Neurological Institute) Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Oscar Martinez, MD No disclosure on file